Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a23c0c98392921ca

Jump to content

// Workers AI · dad joke modeWhy did dermatan sulfate go to therapy? It was feeling a little rough.

From Wikipedia, the free encyclopedia
(Redirected from Dermatan)
Dermatan sulfate
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
ChemSpider
  • none
UNII
CompTox Dashboard (EPA)
ECHA InfoCard100.042.305 Edit this at Wikidata
Chemical and physical data
FormulaC14H21NO15S
Molar mass475.37 g·mol−1
 X markNcheckY (what is this?)  (verify)

Dermatan sulfate is a glycosaminoglycan (formerly called a mucopolysaccharide) found mostly in skin, but also in blood vessels, heart valves, tendons, and lungs.

It is also referred to as chondroitin sulfate B,[1] although it is no longer classified as a form of chondroitin sulfate by most sources. The formula is C14H21NO15S. This carbohydrate is composed of linear polymers of disaccharide units that contain, iduronic acid (IdoA) and N-acetyl galactosamine (GalNAc). These repeating units are sulfated at a variety of positions.[2] Dermatan sulfate is a component of the compound sulodexide.[3]

Function

[edit]

Dermatan sulfate may have roles in coagulation, cardiovascular disease, carcinogenesis, infection, wound repair, maintaining the shape of galactosamine 4-sulfate, skin, and fibrosis.[1]

Pathology

[edit]

Dermatan sulfate accumulates abnormally in several of the mucopolysaccharidosis disorders.

An excess of dermatan sulfate in the mitral valve is characteristic of myxomatous degeneration of the leaflets leading to redundancy of valve tissue and ultimately, mitral valve prolapse (into the left atrium) and insufficiency. This chronic prolapse occurs mainly in women over the age of 60, and can predispose the patient to mitral annular calcification. Mitral valve insufficiency can lead to eccentric (volume dependent or dilated) hypertrophy and eventually left heart failure if untreated.

See also

[edit]

References

[edit]
  1. 1 2 Trowbridge JM, Gallo RL (September 2002). "Dermatan sulfate: new functions from an old glycosaminoglycan". Glycobiology. 12 (9): 117R–125R. doi:10.1093/glycob/cwf066. PMID 12213784.
  2. "Dermatan sulfate".
  3. Lasierra-Cirujeda J, Coronel P, Aza M, Gimeno M (2010). "Use of sulodexide in patients with peripheral vascular disease". Journal of Blood Medicine. 1: 105–115. doi:10.2147/JBM.S10558. PMC 3262318. PMID 22282689. Sulodexide is a highly purified glycosaminoglycan (GAG) obtained from porcine digestive mucosa and is composed of a mixture of 80% heparan sulfate (an electrophoretically fast moving fraction with a low molecular weight of 7000 Da and affinity for antithrombin III) and 20% dermatan sulfate with a high molecular weight (25,000 Da) and affinity for the heparin II cofactor.
[edit]